发明名称 DILTIAZEM CONTROLLED RELEASE FORMULATION AND METHOD OF MANUFACTURE
摘要 A controlled release diltiazem dosage formulation comprising a plurality of diltiazem pellets and a gel-forming material where the time of maximum diltiazem blood plasma levels occurs more than 8 hours after administration and preferably more than 10 hours after administration.
申请公布号 CA2617351(A1) 申请公布日期 2007.02.22
申请号 CA20062617351 申请日期 2006.08.10
申请人 WATSON PHARMACEUTICALS, INC. 发明人 QI, XIAOHONG;CHENG, XUI XUI;ZHANG, GUOHUA;DIXIT, MANESH
分类号 A61K9/26;A61K31/554 主分类号 A61K9/26
代理机构 代理人
主权项
地址